Recursion Pharmaceuticals, Inc. RXRX
3.59 USD +0.04 (+1.13%)
At closeNov 11, 2026, 4:00 PM EST
3.57 -0.02 -0.56%
After hours · Nov 11, 4:00 PM ET
3.53 Day range 3.72
2.77 52-week range 5.24
- YTD
- -12.22%
- 1 year
- -23.78%
RXRX revenue history
Revenue is income from the company’s ordinary business activities.
74,681,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 74,681,000 | 15,842,000 | 26.92% |
| FY 2024 | 2024-12-31 | 58,839,000 | 14,264,000 | 32.00% |
| FY 2023 | 2023-12-31 | 44,575,000 | 4,732,000 | 11.88% |
| FY 2022 | 2022-12-31 | 39,843,000 | 29,665,000 | 291.46% |
| FY 2021 | 2021-12-31 | 10,178,000 | 6,216,000 | 156.89% |
| FY 2020 | 2020-12-31 | 3,962,000 | 1,643,000 | 70.85% |
| FY 2019 | 2019-12-31 | 2,319,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:01:11.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.